APA (7th ed.) Citation

Liu, C., Li, L., Lu, W., Du, H., Yan, L., Wen, T., . . . Xu, M. (2018). A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization. BMC Cancer, 18, 1. https://doi.org/10.1186/s12885-018-4121-3

Chicago Style (17th ed.) Citation

Liu, Chang, Lei Li, Wu-sheng Lu, Hua Du, Lu-nan Yan, Tian-fu Wen, Wu-ran Wei, Li Jiang, and Ming-qing Xu. "A Novel Combined Systemic Inflammation-based Score Can Predict Survival of Intermediate-to-advanced Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization." BMC Cancer 18 (2018): 1. https://doi.org/10.1186/s12885-018-4121-3.

MLA (9th ed.) Citation

Liu, Chang, et al. "A Novel Combined Systemic Inflammation-based Score Can Predict Survival of Intermediate-to-advanced Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization." BMC Cancer, vol. 18, 2018, p. 1, https://doi.org/10.1186/s12885-018-4121-3.